Disitamab Vedotin (RC48) for HER2-positive advanced breast cancer: a case report and literature review by Yang Li, Jingjiao Zhang, Zhengang Cai, Xue Gao, Lina Zhang, Zhi Lu, Xiaojie Wang, Peiyao Yu, Jia Li, Fengqi Fang

Get full text